Efficacy of adjuvant nivolumab versus adjuvant gemcitabine plus cisplatin/carboplatin after radical nephroureterectomy for upper tract urothelial carcinoma: a real-world analysis using a Japanese large-scale claims database. (PubMed, Urol Int) - Oct 16, 2026 - "In Japanese UTUC patients, adjuvant nivolumab may be at least not inferior to GC/GCarbo, suggesting the usefulness of an immunotherapy-after-chemotherapy sequence."
Journal • Real-world evidence • Oncology • Solid Tumor • Urothelial Cancer
|
|
Akihito Hashizume; Daiji Takamoto; Daiki Ueno; Hiroji Uemura; Jun-Ichi Teranishi; Kazuhide Makiyama; Masanobu Yamazaki; Shinnosuke Kuroda; Takashi Kawahara; Takeaki Noguchi; Teppei Takeshima; Yasushi Yumura
|